Abstract:Background and aims As a member of mitochondrial sirtuins, Sirt4 plays a vital role in cellular metabolism and intracellular signal transduction; however, its effect on atherosclerosis is unclear. This study aimed to explore the effect of Sirt4 on atherosclerosis and its underlying mechanism. Methods In vivo , Apoe −/− and Apoe −/− /Sirt4 −/− mice were fed a high-fat diet to induce atherosclerosis. In vitro , peritoneal macrophages from two mouse types were extracted and treated with oxidized low-density lipoprotein to establish a cell model, THP-1 cells were used to observe the effect of Sirt4 on the adhesion ability of monocytes. The growth and composition of aortic plaques in two mouse types were analyzed by H&E staining, Oil Red O staining, Dil oxidized low-density lipoprotein, immunohistochemistry, real-time quantitative polymerase chain reaction and enzyme-linked immunosorbent assay. Transcriptome analysis and Western blotting were performed to explore the specific mechanism. Results Sirt4 deficiency aggravated atherosclerosis in mice. In vivo , aortic plaque size, lipid content, and expression of related inflammatory factors in Apoe −/− /Sirt4 −/− mice were higher than those in the control group, whereas the contents of collagen I and smooth muscle actin-α were significantly lower. Sirt4-deficient macrophages exhibited stronger lipid phagocytosis in vitro , and the adhesion ability of monocytes increased when Sirt4 expression decreased. Transcriptome analysis showed that the expression of CXCL2 and CXCL3 in Sirt4-deficient peritoneal macrophages increased significantly, which may play a role by activating the NF-κB pathway. In further verification, the results in vitro and in vivo showed that the expression of VCAM-1 and pro-inflammatory factors such as IL-6, TNF-α and IL-1β increased, whereas the expression of anti-inflammatory factor IL-37 decreased in Sirt4-deficient peritoneal macrophages and tissues. After blocking the effect with NK-κB inhibitor BAY11-7082, the inflammatory reaction in sirt4 deficient macrophages was also significantly decreased. Conclusions This study demonstrated that Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway, suggesting that Sirt4 may exhibit a protective effect in atherosclerosis, which provides a new strategy for clinical prevention and treatment of atherosclerosis.

Mitochondrial Sirtuin 4 Resolves Immune Tolerance in Monocytes by Rebalancing Glycolysis and Glucose Oxidation Homeostasis.

Switch of NAD Salvage to De Novo Biosynthesis Sustains SIRT1-RelB-Dependent Inflammatory Tolerance

Frontline Science: Monocytes sequentially rewire metabolism and bioenergetics during an acute inflammatory response

Sirtuins Link Inflammation and Metabolism

NAD+ Dependent Deacetylase Sirtuin 5 Rescues the Innate Inflammatory Response of Endotoxin Tolerant Macrophages by Promoting Acetylation of P65.

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Myeloid Deletion of SIRT1 Induces Inflammatory Signaling in Response to Environmental Stress.

Metabolic mechanisms orchestrated by Sirtuin family to modulate inflammatory responses

Roles of SIRT1 in the Acute and Restorative Phases following Induction of Inflammation

ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis

Mitochondrial dysfunction caused by SIRT3 inhibition drives proinflammatory macrophage polarization in obesity

Immunometabolic Endothelial Phenotypes

The Roles of Mitochondrial SIRT4 in Cellular Metabolism

SIRT6 stabilization and cytoplasmic localization in macrophages regulates acute and chronic inflammation in mice

Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway

SIRT3 (Sirtuin-3) Prevents Ang II (angiotensin II)-Induced Macrophage Metabolic Switch Improving Perivascular Adipose Tissue Function.

Sirtuin 3 Governs Autophagy‐dependent Glycolysis During Angiotensin II‐induced Endothelial‐to‐mesenchymal Transition

Sirtuins in macrophage immune metabolism: A novel target for cardiovascular disorders

Mitochondrial dysfunction in macrophages promotes inflammation and suppresses repair after myocardial infarction

VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism

Inflammatory Macrophages Reprogram to Immunosuppression by Reducing Mitochondrial Translation